Redhill Biopharma Ltd (NASDAQ:RDHL)
| 0.266 Delayed Data As of Dec 02 |  -0.099 / -27.12%Today’s Change | 0.25 Today|||52-Week Range 3.37 | -89.69% Year-to-Date |
Latest RDHL News | Press Releases
No recent news for Redhill Biopharma Ltd.
Today’s Trading
| Previous close | 0.37 |
| Today’s open | 0.26 |
| Day’s range | 0.25 - 0.28 |
| Volume | 453,353 |
| Average volume (3 months) | 2,565,232 |
| Market cap | $22.8M |
Data as of 3:59pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | -905.40% |
| Earnings growth (this year) | +96.67% |
| Earnings growth (next 5 years) | +113.00% |
| Revenue growth (last year) | +33.34% |
| P/E ratio | NM |
| Price/Sales | 1.40 |
| Price/Book | 2.53 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ENTXEntera Bio Ltd | 0.00 | 0.00% |
| ACSTAcasti Pharma Inc | -0.01 | -1.28% |
| NLTXNeoleukin Therapeuti... | +0.02 | +3.42% |
| NERVMinerva Neuroscience... | -0.19 | -5.29% |
Data as of 3:59pm ET, 12/02/2022
Financials
| Next reporting date | February 23, 2023 |
| EPS forecast (this quarter) | $0.00 |
| Annual revenue (last year) | $85.8M |
| Annual profit (last year) | -$97.8M |
| Net profit margin | -113.98% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
